KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for TherapeuticsMD (TXMD) over the last 3 years, with Dec 2024 value amounting to $11,532.

  • TherapeuticsMD's Shares Outstanding (Diluted Average) rose 0.36% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 0.36%. This contributed to the annual value of $11,532 for FY2024, which is 10.45% up from last year.
  • Per TherapeuticsMD's latest filing, its Shares Outstanding (Diluted Average) stood at $11,532 for FY2024, which was up 10.45% from $10,441 recorded in FY2023.
  • TherapeuticsMD's Shares Outstanding (Diluted Average)'s 5-year high stood at $9.4 million during FY2022, with a 5-year trough of $10,441 in FY2023.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $3.1 million, with a median of $11,532 in 2024.
  • Per our database at Business Quant, TherapeuticsMD's Shares Outstanding (Diluted Average) crashed by 99.89% in 2023 and then climbed by 10.45% in 2024.
  • Yearly analysis of 3 years shows TherapeuticsMD's Shares Outstanding (Diluted Average) stood at $9.4 million in 2022, then crashed by 99.89% to $10,441 in 2023, then climbed by 10.45% to $11,532 in 2024.